Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
4.100
-0.330 (-7.45%)
At close: Jan 29, 2026, 4:00 PM EST
4.100
0.00 (0.00%)
After-hours: Jan 29, 2026, 6:54 PM EST
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $5.94 million as of January 29, 2026. Its market cap has decreased by -64.56% in one year.
Market Cap
5.94M
Enterprise Value
-997.71K
1-Year Change
-64.56%
Ranking
Category
Stock Price
$4.10
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $5.94M, a decrease of -67.86%. That is a compound annual growth rate of -6.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 5.95M | -75.87% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adial Pharmaceuticals | 6.39M |
| Bio Green Med Solution | 6.37M |
| Silexion Therapeutics | 6.27M |
| BiomX | 6.26M |
| 60 Degrees Pharmaceuticals | 6.23M |
| Abpro Holdings | 6.03M |
| Xenetic Biosciences | 5.84M |
| Aprea Therapeutics | 5.73M |